Neurology Specific Literature Search   

(Click to cross reference)
anti Ma
anti MAG antibodies
anti Ta
brain biopsy
carcinoma of lung
CAT scan, emission
CAT scan, emission, abnormal
cerebellar atrophy, secondary
cerebellar degeneration
cerebrospinal fluid, abnormal
cerebrospinal fluid, elevated protein of
congenital myasthenic syndromes
electromyogram, decremental response
encephalitis, autoimmune
encephalitis, brainstem
encephalitis, paraneoplastic
gait disorder
hydrocephalus, acute
hydrocephalus, non-communicating(obstructive)
intellectual deficit
limbic encephalitis
malignancy, occult
mediastinum, mass of
memory, defect of recent
memory, impairment of
MRI, abnormal
MRI, contrast enhanced
myasthenia gravis
myasthenia gravis, congenital
myasthenia gravis, etiology of
myasthenia gravis, familial incidence of
myasthenia gravis, seronegative
neuromuscular disease, electrodiagnosis of
opsoclonus-myoclonus syndrome
pleocytosis of cerebrospinal fluid
progressive neurologic disorder
ptosis, bilateral
remote effect of cancer on the nervous system
repetitive nerve stimulation
review article
serum tumor markers
sleep pathology and physiology
temporal lobe, lesion
temporal lobe, lesion, bilateral
tensilon test, false negative
testicular germinoma
testicular teratoma
treatment of neurologic disorder
walking, difficulty with
Showing articles 0 to 50 of 1236 Next >>

Opsoclonus in Anti-Ma2 Brain-Stem Encephalitis
NEJM 383:e84, Sacks, C.A.,et al, 2020

A 30-year-old man with headache and sleep disturbance
Neurol 90:e1535-e1540, English, S.W.,et al, 2018

Subacute Progressive Ptosis, Ophthalmoplegia, Gait Instability, and Cognitive Changes
JAMA Neurol 75:1284-1285, Lin, J.,et al, 2018

Anti-Ma and Anti-Ta Associated Paraneoplastic Neurological Syndromes: 22 Newly Diagnosed Patients and Review of Previous Cases
JNNP 79:767-773,742, Hoffmann,L.A.,et al, 2008

Congenital Myasthenic Syndromes
In:Neurologic Clinics, 12:401-4371994., Engel,A.G., 1994

Paraneoplastic Myeloneuropathies
Neurol 96:e632-e639, Shah, S.,et al, 2021

Cranial Nerve Disorders Associated with Immune Checkpoint Inhibitors
Neurol 96:e866-e875, Vogrig, A.,et al, 2021

Sensory Ganglionopathy
NEJM 383:1657-1662, Amato, A.A. & Ropper, A.H., 2020

NEJM 383:1866-1876, Ashina, M., 2020

Central Nervous System Involvement in Erdheim-Chester Disease
Neurol 95:e2746-e2754, Aubart,F.C.,et al, 2020

Clinical features, prognostic factors, and antibody effects in anti-mGluR1 encephalitis
Neurol 95:e3012-e3025, Spatola, M.,et al, 2020

An 11-year-old girl with focal seizures, fevers, and unilateral, enhancing cortical lesions
Neurol 95:e3153-e3159, Russ, J.B.,et al, 2020

Imaging Review of Paraneoplastic Neurologic Syndromes
AJNR 41:2176-2187, Madhavan, A.A.,et al, 2020

Hashimoto Encephalopathy in the 21st Century
Neurol 94:e217-e224, Mattozzi, S.,et al, 2020

Palatal Myoclonus, Abnormal Eye Movements, and Olivary Hypertrophy in GAD65-Related Disorder
Neurol 94:273-275, Macaron, G.,et al, 2020

Infection Risks Among Patients with Multiple Sclerosis Treated with Fingolimod, Natalizumab, Rituximab, and Injectable Therapies
JAMA Neurol 77:184-191, Luna, G.,et al, 2020

Randomized Placebo-Controlled Trial of Intravenous Immunoglobulin in Autoimmune LGI1/CASPR2 Epilepsy
Ann Neurol 87:313-323, Dubey, D.,et al, 2020

Randomized Placebo-Controlled Trial of Intravenous Immunoglobulin in Autoimmune LGI1/CASPR2 Epilepsy
Ann Neurol 87:313-323, Dubey, D.,et al, 2020

A Rare Presentation of Whipple Disease
Neurol 94:e758-e761, Koek, A.T.,et al, 2020

Myasthenia Gravis Following Dabrafenib and Trametinib for Metastatic Melanoma
Neurol 94:322-323, Zaloum, A.,et al, 2020

New Onset Weakness in the Face and Arm
BMJ 368:L7077, Brites, L.,et al, 2020

Epilepsy in Older People
Lancet 395:735-748, Sen, A.,et al, 2020

Management and Outcome of Primary CNS Lymphoma in the Modern Era
Neurol 94:e1027-e1039, Houillier, C., et al, 2020

Anti-NMDAR Encephalitis with Overlapping Demyelinating Syndrome
Neurol 94:e1866-e1869, Kim, H.W., et al, 2020

A 47-year-old Man with Rapidly Progressive Ataxia and Vitiligo
Neurol 94:e1664-e1669, Han, F.,et al, 2020

A 16-year-old Girl with Ataxia, Oscillopsia, and Behavioral Changes
Neurol 94:713-717, Silverman, A.,et al, 2020

Severe Neurological Toxicity of Immune Checkpoint Inhibitors: Growing Spectrum
Ann Neurol 87:659-669, Dubey, D.,et al, 2020

Morvan Syndrome and Diffuse Large B-Cell Lymphoma in the Central Nervous System
Neurologist 25:73-77, Jiang, C.,et al, 2020

Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19
NEJM 382:e38, Zhang, Y.,et al, 2020

Spasms and Myoclonus in a Young Woman with Hashimoto Thyroiditis
JAMA Neurol 77:650-651, Shen, D.,et al, 2020

Clinicopathologic Conference, LGI1 autoimmune encephalitis
NEJM 382:1943-1950, Case 15-2020, 2020

Relapse of Severe Neurosarcoidosis with Switch from Originator Infliximab to Biosimilar
Neurol 94:991-993, Kidd, D.P.,et al, 2020

CASPR2 Autoimmunity in Children Expanding to Mild Encephalopathy with Hypertension
Neurol 94:e2290-e2301,953, Syrbe, S.,et al, 2020

Severe Neurological Toxicity of Immune Checkpoint Inhibitors: Growing Spectrum
Ann Neurol 87:659-669, Dubey, D.,et al, 2020

Association of Innovations in Radiotherapy and Systemic Treatments with Clinical Outcomes in Patients with Melanoma Brain Metastasis From 2007 to 2016
JAMA doi:10.1001/JAMANETWORKOPEN.2020.8204, Brastianos, H.C.,et al, 2020

Paraneoplastic Encephalomyelitis with Glutamic Acid Decarboxylase Antibodies Presenting as Longitudinal Pyramidal Tract Hyperintensity
JAMA Neurol 77:899-900, Miralles, C.,et al, 2020

Second Drug Okayed for Rare Central Nervous System Disease
JAMA 324:224, Jaklevic, M.C., 2020

One-Year Sustained Efficacy of Erenumab in Episodic Migraine
Neurol 95:e469-e479, Goadsby, P.J.,et al, 2020

Polymyalgia Rheumatica and Giant Cell Arteritis
JAMA 324:993-994, Buttgereit, F.,et al, 2020

A Young Generalized Dystonia Patient with Globus-Pallidus-Specific Lesion
Ann Neurol 88:637-638, Wu, H.,et al, 2020

An Adolescent Girl Presenting with Worsening Vertigo, Headache, and Ataxia
Neurol 95:e1760-e1763, Brigham, E.,et al, 2020

Treatment Approaches for MOG-Ab-Associated Demyelination in Children
Curr Treat Options Neurol 21:2, Hacohen, Y. & Banweil, B., 2019

Inebilizumab for the Treatment of Neuromyelitis Optica Spectrum Disorder (N-MOmentum): A Double-Blind, Randomised Placebo-Controlled Phase 2/3 Trial
Lancet 394:1352-1363,1304, Cree, B.A.C.,et al, 2019

Acute Rheumatic Fever: Clinical Manifestations and Diagnosis, Oct, Steer, A. & Gibofsky, A., 2019

Targeting Calcitonin Gene-Related Peptide: A New Era in Migraine Therapy
Lancet 394:1765-1774, Charles, A. & Pozo-Rosich, P., 2019

Amphiphysin-IgG Autoimmune Neuropathy
Neurol 93:e1873-e1880, Dubey, D.,et al, 2019

Clinicopathologic Conference, Lymphocytic Choriomeningitis Virus Infection
NEJM 381:2553-2560, Case Record 40-2019, 2019

Neuromuscular Adverse Events Associated with Anti-PD-1 Monoclonal Antibodies
Neurol 92:663-674, Johansen, A.,et al, 2019

Pembrolizumab Treatment for Progressive Multifocal Leukoencephalopathy
NEJM 380:1597-1605, Cortese, I.,et al, 2019

Showing articles 0 to 50 of 1236 Next >>